Indivior Stock (NASDAQ: INDV) stock price, news, charts, stock research, profile.
Open | $10.25 |
Close | $10.40 |
Volume / Avg. | 1.50M / 239.68K |
Day Range | 10.01 - 10.50 |
52 Wk Range | 9.14 - 24.90 |
Market Cap | $1.39B |
P/E Ratio | 271.00 |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 23 |
Short Interest | - |
Days to Cover | 1 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Indivior (NASDAQ:INDV) through any online brokerage.
Other companies in Indivior’s space includes: Verona Pharma (NASDAQ:VRNA), Supernus Pharmaceuticals (NASDAQ:SUPN), Tarsus Pharmaceuticals (NASDAQ:TARS), Rapport Therapeutics (NASDAQ:RAPP) and Neumora Therapeutics (NASDAQ:NMRA).
There is no analysis for Indivior.
Indivior has a consensus price target of $24.00.
The stock price for Indivior (NASDAQ: INDV) is $10.4 last updated July 15, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Indivior.
Indivior’s Q2 earnings are confirmed for Monday, July 29, 2024.
There is no upcoming split for Indivior.
Indivior is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.